Home>Topics>Funds>iShares Nasdaq Biotechnology

iShares Nasdaq Biotechnology

  1. All
  2. Commentary
  3. Fund Reports
  4. ETF Reports
  5. Headlines
  1. Viking Therapeutics debuts this week

    Headlines

    Sun, 14 Sep 2014

    orally-available drug for the treatment of cancer cachexia . Phase 2 clinical trials are expected to commence for both product candidates in early 2015 with projected completion dates in 2016. S-1 ETFs: IBB , BIB , BIS IPO Post your comment!

  2. Tokai Pharma IPO slated for this week

    Headlines

    Sun, 14 Sep 2014

    trial, it demonstrated clinically meaningful reductions in PSA (prostate specific antigen). IPO proceeds will fund a Phase 3 trial for galeterone that is expected to commence in 1H 2015. S-1 ETFs: IBB , BIB , BIS IPO Post your comment!

  3. rEVO Biologics IPO set for this week

    Headlines

    Sun, 14 Sep 2014

    label into other indications, like preeclampsia (PE). Proceeds from IPO will fund the Phase 3 trial of Atryn to manage PE, ramp up the sales effort and for general corporate purposes. S-1 ETFs: IBB , BIB , BIS IPO Post your comment!

  4. ProQR Therapeutics debuts this week

    Headlines

    Sun, 14 Sep 2014

    single protein is defective. Its lead product is the Orphan Drug-designated QR-010 for the treatment of Cystic Fibrosis (CF). It has only been evaluated in preclinical studies, however. F-1 ETFs: IBB , BIB , BIS IPO Post your comment!

  5. Foamix Pharma debuts this week

    Headlines

    Sun, 14 Sep 2014

    labeling of a 71% success rate after eight days and 96% after 12 days. The company plans to initiate Phase 3 clinicals for FMX101 for acne in 2015 as well as FMX102 for impetigo in 2H 2015. F-1 ETFs: IBB , BIB , BIS IPO Post your comment!

  6. Biotech firms set to debut next week

    Headlines

    Fri, 12 Sep 2014

    Biotech IPOs set for next week: Foamix Pharaceuticals (FOMX); ProQR Therapeutics (PRQR); rEVO Biologics (RBIO); Tokai Pharmaceuticals (TKAI); Viking Therapeutics (VKTX) ETFs: IBB , BIB , BIS IPO Post your comment!

  7. New Issue- IBB prices 100 mln euro 2015 bond

    Headlines

    Wed, 10 Sep 2014

    For news about this issuer, double click on the issuer RIC,

  8. Briefing docs out for upcoming Ad Comm meeting on polypill

    Headlines

    Mon, 8 Sep 2014

    disease. Polypills potentially combine multiple drugs (e.g. aspirin, beta-blocker, statin, ACE-inhibitor) in one pill to treat cardiovascular disorders. ETFs: IBB , BIB , IRY , BIS , IXJ , DRGS Briefing docs Post your comment!

  9. Qardio releases Android app for personal blood pressure monitor

    Headlines

    Wed, 3 Sep 2014

    and sync information to the Qardio cloud. Qardio has generated substantial buzz over its portable monitoring technology. It also provides a wearable ECG monitor called QardioCore. ETFs: IBB , BIB , IRY , IXJ , BIS , DRGS Post your comment!

  10. XBI SPDR S&P Biotech ETF ETF Analysis, Report, Research, 5 Star Rating – Morningstar

    ETF Reports

    Tue, 2 Sep 2014

    market-cap-weighted option is iShares Nasdaq Biotechnology IBB , which holds 121 Nasdaq-listed ..... market cap of $16.3 billion. IBB charges an expense ratio of 0 ..... holding cost of just 0.27%. IBB has a low price tag, historically

« Prev1234Next »
Content Partners